3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
5
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Esophageal Neoplasms
7
Breast Neoplasms
6
Stomach Neoplasms
4
Uterine Cervical Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymoma
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Carcinoma, Ovarian Epithelial
1
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
1
Interventions
Cisplatin
2
avelumab
1
Paclitaxel
1
Ifosfamide
1
Everolimus
1
Disulfiram
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms, Germ Cell and Embryonal
×
Paclitaxel
×
Clear all
NCT02414685
2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2
Completed
19 enrolled